Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FIT Combining FC for Predicting MH and Histology Remission in UC

NCT05447572 is registered in ClinicalTrials.gov with Shandong University as lead sponsor.

NCT NCT05447572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05447572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FIT Combining FC for Predicting MH and Histology Remission in UC
Lead sponsor
Shandong University
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2021
Completion date
December 12, 2023
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fecal calprotetin, fit, histology remission, mucosal healing, ulcerative colitis